Andreas Schlesinger
St. Marien Hospital(DE)University Hospital Cologne(DE)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Fibroblast Growth Factor Research, Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research
Most-Cited Works
- → MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung(2014)189 cited
- → Early Prediction of Nonprogression in Advanced Non–Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography(2011)171 cited
- → Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer(2012)129 cited
- → Regional screening network for characterization of the molecular epidemiology of non-small cell lung cancer (NSCLC) and implementation of personalized treatment.(2012)10 cited
- → Task Force Dyspnoe Unit (DU)(2024)3 cited
- → Dyspnoe Units – Empfehlungen zu personellen, strukturellen und technischen Voraussetzungen(2025)1 cited
- → Frequency and clinical characterization of NSCLC patients harboring PIK3CA mutations identified within a regional screening network.(2012)
- → Management of lung cancer in older adults(2025)
- → Clinical characteristics and natural history of patients with squamous cell lung carcinoma with FGFR1 amplification.(2012)